PhRMApedia Press Room
PhRMApedia's Press Room will provide the most recent press releases. Search PhRMApedia for additional press releases. PhRMApedia is your new resource hub. You can search our entire database of media releases, reports, white papers, videos and more. Type your keywords in the search bar and explore PhRMA’s resources. Search results will appear by type, title and date.
Washington, D.C. (February 5, 2015) — Pharmaceutical Research and Manufacturers of America (PhRMA) President and Chief Executive Officer, John Castellani, provided the following statement:
“PhRMA salutes the work of Commissioner Hamburg and recognizes her significant contributions to the thoughtful regulation of medicines, including science as a basis for better regulatory decisions. For nearly six years, and to the direct benefit of patients, Commissioner Hamburg has demonstrated strong leadership and an unwavering commitment to collaboration with all stakeholders.
“We look forward to working with the FDA’s leadership and Acting Commissioner Ostroff to bring safe and effective innovative medicines to patients.”
Washington, D.C. (January 27, 2015) — Pharmaceutical Research and Manufacturers of America (PhRMA) President and Chief Executive Officer John J. Castellani issued the following statement on the newly released 21st Century Cures discussion draft:
"We appreciate the opportunity to review the discussion draft released today and look forward to providing feedback to the House Energy and Commerce Committee.
“PhRMA supports the Committee’s goal of accelerating the discovery, development and delivery of new medicines for patients and provided feedback on several of the 21st Century Cures whitepapers.”
Washington, D.C. (January 26, 2015) — Pharmaceutical Research and Manufacturers of America (PhRMA) president and chief executive officer John J. Castellani issued the following statement on Health and Human Services (HHS) Secretary Sylvia Mathews Burwell’s announcement on payment and delivery reform:
"PhRMA supports Secretary Burwell’s goal of advancing affordable, high quality and patient centered health care, and today’s announcement represents an important step forward.
Washington, D.C. (January 22, 2015) — Pharmaceutical Research and Manufacturers of America (PhRMA) senior vice president, communications, Robert Zirkelbach released the following statement:
Washington, D.C. (December 22, 2014) — Pharmaceutical Research and Manufacturers of America (PhRMA) Deputy President, Mark Grayson issued the following statement:
"PhRMA welcomes today’s release of the U.S. International Trade Commission report on 'Trade, Investment, and Industrial Policies in India: Effects on the U.S. Economy.' The report is useful in documenting the challenges U.S. business faces in India, but also the potential benefits to both economies from addressing existing trade barriers. For example, the report identifies that improved IP protection would have 'substantial positive effects' on U.S. exports to India and increased economic engagement in India.
Washington, D.C. (December 18, 2014) — Today, the Pharmaceutical Research and Manufacturers of America (PhRMA) released a new report, “Twenty-Five Years of Progress Against Hepatitis C: Setbacks and Stepping Stones,” that examines the scientific challenges and setbacks researchers have faced on the path to developing new medicines with the potential to transform treatment for hepatitis C patients and how these so-called “failures” are an integral part of the drug discovery process.
Washington, D.C. (November 20, 2014) — Pharmaceutical Research and Manufacturers of America (PhRMA) Senior Vice President, Robert Zirkelbach issued the following statement:
“AARP has released another disingenuous report on prescription drug spending that cherry-picks data to advance a narrative that simply doesn’t match reality. The findings from the report have been contradicted by numerous studies, including recent federal government data showing that prescription drug spending will continue to grow at the same rate as overall health care costs over the next decade.”
In reviewing AARP’s report, other points to consider include:
Washington, D.C. (January 29, 2014) — Pharmaceutical Research and Manufacturers of America (PhRMA) President and CEO John J. Castellani issued the following statement:
"President Obama’s address comes at a time when America’s biopharmaceutical research companies are bringing pioneering new medicines to patients, supporting high-value American jobs and helping strengthen local communities and our national economy. Continued progress – the kind that President Obama urged for last night – is only possible, however, if we fully embrace innovation.
"The President referenced patent reform and we look forward to working with the Senate on targeted reforms to curb abusive patent litigation while maintaining incentives for biomedical innovation.
Washington, DC (October 20, 2014)– The Pharmaceutical Research and Manufacturers of America (PhRMA) announced today that Christina (“Tina”) Stow will join the organization as Vice President of Communications, effective October 27, 2014.
Stow will play a key leadership role within the communications department. She will oversee a team responsible for the day-to-day activities associated with media relations, including message development, proactive media outreach, rapid response, message research and relationship-building with key reporters and influencers. Stow will report to Robert Zirkelbach, Senior Vice President of Communications.
Washington, DC – Pharmaceutical Research and Manufacturers of America (PhRMA) President and CEO John Castellani today issued the following statement on the selection of Ron Klain to manage the U.S. government’s response to preventing the spread of the Ebola virus:
“Protecting patients and their families from the devastating effects of Ebola is a national priority. As Mr. Klain takes on the important and challenging role of coordinating the government’s response to the Ebola outbreak, our industry stands ready to support these efforts by using our resources and expertise to assist patients and their families affected.
Washington, D.C. (October 14, 2014) — Today, the Pharmaceutical Research and Manufacturers of America (PhRMA) launched Access Better Coverage.org, a new website designed to educate consumers about the ABCs of health coverage and access to prescription medicines.
The new site introduces important resources to help people better understand how health insurance works and what to expect from their coverage, including a series of white board videos explaining basic insurance terms like deductibles, copays and coinsurance, and how formularies and tiers work.
Washington, D.C. (October 7, 2014) — Today, the Pharmaceutical Research and Manufacturers of America (PhRMA) released a new report, “Researching Cancer Medicines: Setbacks and Stepping Stones,” which highlights the number of investigational cancer medicines that did not succeed in clinical trials and how these so-called “failures” are a critical part of the drug development process.
Washington, D.C. (October 3, 2014) – Today, the Pharmaceutical Research and Manufacturers of America (PhRMA) launched a campaign, called “I'm Not Average,” to share inspirational stories from patients about the powerful impact advances and innovations in cancer medicines have had on their lives.
Washington, D.C. (September 30, 2014) — Pharmaceutical Research and Manufacturers of America (PhRMA) associate general counsel, John Murphy, issued the following statement regarding the Centers for Medicare & Medicaid Services’ (CMS) public release of the Open Payments database – a database established through the Physician Payments Sunshine Act included in the Affordable Care Act.